(Q46171586)

20 December 2017

title

Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301. (English)

1 reference

20 December 2017

author

Vesa Oikonen

7

1 reference

20 December 2017

Juha O. Rinne

12

object named as

J O Rinne

1 reference

20 December 2017

author name string

J Hirvonen

1

1 reference

20 December 2017

M Kailajärvi

2

1 reference

20 December 2017

T Haltia

3

1 reference

20 December 2017

S Koskimies

4

1 reference

20 December 2017

K Någren

5

1 reference

20 December 2017

P Virsu

6

1 reference

20 December 2017

H Sipilä

8

1 reference

20 December 2017

P Ruokoniemi

9

1 reference

20 December 2017

K Virtanen

10

1 reference

20 December 2017

M Scheinin

11

1 reference

20 December 2017

language of work or name

English

0 references

publication date

7 January 2009

1 reference

20 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

20 December 2017

volume

85

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

506-512

1 reference

20 December 2017

Current pharmacotherapy for Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Platelet monoamine oxidase B activity in dementia. A 4-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

7 January 2021

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

7 January 2021

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

7 January 2021

Production and quality control of 15O2 and C15O2 for medical use

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.241

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.241

1 reference

20 December 2017

1 reference

20 December 2017